Role of IgM and C-reactive protein in ischemia reperfusion injury
| Autor: | Diaz Padilla, N. |
|---|---|
| Přispěvatelé: | Daha, M.R., Leiden University |
| Jazyk: | angličtina |
| Rok vydání: | 2007 |
| Předmět: |
ischemia reperfusion injury
Platelet activating factor Lyso-Pc Lysophosphatidylcholine IgM antibody to phosphorylcholine TNF PAF C1-inhibitor Fc_R Tumor necrosis factor acute myocardial infarction C-reactive protein AMI IRI Anti-Pc IgM Fc gamma receptors C1-Inh CPS C-polysaccharide of pneumococci CRP |
| Zdroj: | None |
| Popis: | Ischemia-reperfusion injury (IRI) is a pathophysiological event that occurs in many clinical conditions, ranging from surgery, acute artery occlusion to transplantation. Complement activation is thought to be a crucial step in IRI, because complement inhibition and complement deficiency considerably attenuate irreversible injury. However, the specific complement pathway remains unclear. All three complement pathways: the classical, the alternative, and the mannose-binding lectin dependent pathway may be involved in the development of IRI, depending on the model, the tissue, and the time course of inflammation. Ischemia leads to the exposition of neoantigens on the jeopardized tissues, which could be recognized by C-reactive protein (CRP) and natural IgM antibodies. The binding of CRP and IgM to these neoepitopes is followed by complement activation. In this thesis, we demonstrated that both proteins bind to jeopardized tissues and activate the complement system, in particular intestines from rats subjected to IRI. Furthermore, it was shown that IgM levels against altered phospholipids correlated with the levels of inflammatory mediators in patients subjected to tissue damage suggesting that IgM participates in amplification of inflammation. The development of strategies to prevent binding of CRP and/or IgM is an attractive approach for a therapy for reducing IRI. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|